Repeat Diagnostics 🇨🇦

RepeatDx is an accredited clinical diagnostics laboratory using Flow FISH analysis for telomere length measurement🧬(2 and 6 - Panel). Helping #IPF🫁 & #DC🩸.

[Repeat Diagnostics 🇨🇦 @RepeatDx]

Repeat Dx is a clinical diagnostics laboratory committed to the utmost quality of clinical service for telomere length testing🧬.The Flow FISH method (2-panel and 6-panel) aids in disease course prediction and guides treatment decisions for DC🩸and PF🫁. https://t.co/L4HNBCEg7r

[Repeat Diagnostics 🇨🇦 @RepeatDx]

What a remarkable year it's been for Repeat Diagnostics! As we look ahead to 2025, we're excited to celebrate a major milestone—our 20th anniversary. Wishing you a joyful holiday season and a fantastic new year! Merry Lab Celebration! ▶️https://t.co/zVRMesyMjO

[Dr. David J. Young, MD PhD @DrDavidJYoung]

Follow up of @nih_nhlbi Danazol for #TBD by @NickLeeMD :

Danazol remains safe and effective. Most require life-long treatment, but organ dysfunction and infection (esp pulmonary) continues. Absent other risks (e.g., immune AA) clonal expansion is not seen. #ASH24 #HemeTwitter

[Emma M. Groarke @emmamgroarke]

Amazing talk from our @nih_nhlbi fellow @NickLeeMD presenting long-term results from our high-dose Danazol protocol for patients with #TBD. #ASH24 @ASH_hematology @NCICCR_MOS @NealSYoung1 @fergutierrezro1 @bhavishap29 @TeamTelomereInc

[Emma M. Groarke @emmamgroarke]

A nice commentary in this issue of @BloodJournal for our paper looking at the role of #ClonalHematopoiesis in #TBD from @Chris_R_Reilly and @myllymaki_mikko - a somatic symphony; telomeres and CH! https://t.co/Ir7UjkieWq @fergutierrezro1 @SharonSavageMD https://t.co/Ir7UjkieWq

[Fernanda Gutierrez-Rodrigues @fergutierrezro1]

Our #ClonalHematopoiesis paper is finally featured in the latest @BloodJournal issue! A huge collaboration among #TBD experts @emmamgroarke @NealSYoung1 @SharonSavageMD @CarmemBonfim1 @TeamTelomereInc https://t.co/F0uzGXGHzd @nih_nhlbi #BMFsm #MDSsm

[Emma M. Groarke @emmamgroarke]

For #GivingTuesday consider donating to @TeamTelomereInc who provide excellent support to our #telomere biology patients! 🧬

[Repeat Diagnostics 🇨🇦 @RepeatDx]

New to pulmonary fibrosis? The @PFFORG is here to guide you! They've compiled trusted resources and expert insights for newly diagnosed patients. Hats off to PFF for their incredible work! 💙 https://t.co/MlI37vtlpq
#Telomere #IPF

[CHEST @accpchest]

What is the clinical impact of telomere length testing on the management of #InterstitialLungDisease? Read the full research in the November issue of the journal CHEST®: https://t.co/7ERp1SJMC9
#MedEd #MedTwitter

[Team Telomere @TeamTelomereInc]

Today we are sharing our Clinical Guidelines & the impact they have made across the world.

To order or download a copy of the CGs or our One Pagers head to our website site today ➡️ https://t.co/K9UFPZ8Stb

#TBDawareness #TeamTelomere15

[Emma M. Groarke @emmamgroarke]

@SharonSavageMD from @theNCI giving an excellent talk on non-hematology complications of #telomere biology disorders. Highlights include liver and lung disease, osteoporoses, and solid cancer risk. @TeamTelomereInc #ESHBMFS2024 @ESHaematology

[Repeat Diagnostics 🇨🇦 @RepeatDx]

Kudos to @TeamTelomereInc 👏for going beyond just raising awareness about Telomere Biology Disorder (TBD). They're connecting top experts in both clinical and research fields.

[UMN Medical School @umnmedschool]

We are excited to announce that the University of Minnesota and @MHealthFairview have been recognized as a @TeamTelomereInc Center of Excellence for Telomere Biology Disorders (TBDs)!

Read more: https://t.co/DejWw7T5w5.

#Telomere | #TBDs

[Emma M. Groarke @emmamgroarke]

My colleague @fergutierrezro1 giving an excellent talk at #ESHBMFS2024 on the clinical implications of clonal hematopoiesis in #telomere biology disorders 🧬; dependent on specific mutation with U2AF1, TP53, and chr1+ associated with #MDSsm and #AMLsm. @nih_nhlbi @ESHaematology

[Emma M. Groarke @emmamgroarke]

Very nice talk from Fabian Beier @RWTH on #HCT in #telomere biology disorders; ongoing high morbidity and mortality related to secondary organ damage. Non-alkylator/TBI regimens and gene therapy promising. @TeamTelomereInc @KMyersBMT @Agarwal_Lab @ESHaematology #ESHBMFS2024

[Repeat Diagnostics 🇨🇦 @RepeatDx]

November marks Telomere Biology Disorder (TBD) Awareness Month🧬—a time dedicated to illuminating a complex yet critical area of health that impacts many lives. https://t.co/D16qMbn9gc
#TBDMonth, #Telomeres, #Telomere, #IPF

[Emma M. Groarke @emmamgroarke]

Our lab will present two #telomere biology disorder abstracts this year at @ASH_hematology #ASH24. First, our @nih_nhlbi fellow @NickLeeMD will be presenting the long-term results of our phase II trial using Danazol @ the Sunday oral #IBMFS session. https://t.co/YSqRx5wxt9 1/2 👇

[Repeat Diagnostics 🇨🇦 @RepeatDx]

Rare germline pathogenic variants (GPVs) in #telomere maintenance genes can lead to telomere biology disorders (TBDs) like bone marrow failure and #IPF, while others cause cancer predisposition with long #telomeres (CPLT). Excellent article from CCCTAA👏
https://t.co/rX8jzYBm0s

[ERS @EuroRespSoc]

New ERS Interactive Education case-based video now available: ‘The challenges of diagnosing ILD’.

The 2nd video in this new series will improve participants’ ability to interpret chest x-rays & HRCT patterns associated with ILDs.

https://t.co/TNSYcBwxWR

[Team Telomere @TeamTelomereInc]

Welcome to Scientific Summit Scenes where we share highlights from #TTSummit24! Today we’re spotlighting Session 2: Clonal Hematopoiesis in #TBDs. Our attendees explored the landscape of clonal hematopoiesis in TBDs and its clinical implications. Stay tuned for more scenes!

[Fernanda Gutierrez-Rodrigues @fergutierrezro1]

CH in Telomere biology disorders as predictors of #MDS! As Chr1q+, U2AF1-S34 leads to TP53 pathway deregulation in HSCs with dysfunctional telomeres. Now online! #TBD #clonalHematopoiesis